Centene Closes Magellan Health Acquisition; Michael Neidorff Quoted

Centene (NYSE: CNC) wrapped up its acquisition of Magellan Health days after the St. Louis-based managed care company obtained all needed regulatory approvals to close the transaction.

“Magellan will expand Centene’s reach to provide increased access to behavioral healthcare for our members at a time when so many Americans are struggling with mental or behavioral health issues,” Michael Neidorff, chairman and CEO of Centene, said in a statement published Tuesday.

Magellan Health will continue to operate as an independent company as part of Centene’s Health Care Enterprises. Magellan Health CEO Ken Fasola and other members of the company’s leadership team will continue to oversee the organization.

“This transaction establishes a strong foundation from which we will innovate and reimagine behavioral and specialty health to provide comprehensive and integrated healthcare to our members, while generating value for our state partners and shareholders,” added Neidorff.

In January 2021, Centene agreed to buy Magellan Health for approximately $2.2 billion, or $95 per share in cash, as part of efforts to expand its whole health capabilities and create a behavioral health platform.

Video of the Day

GovCon Wire Logo

Sign Up Now! GovCon Wire provides you with Daily Updates and News Briefings about M&A Activity

Related Articles

Become a Registered Reader
Register to enjoy unlimited access to articles, interviews, and invaluable govcon content. You'll also receive our daily briefing straight to your inbox.

This will close in 0 seconds